ALB and neoplasm: The patient received 2 cycles combination immunotherapy and platinum-based chemotherapy, specifically: sintilimab 200 mg d1 + paclitaxel for injection (albumin bound) 400mg d1 + Cisplatin 500mg d1 every three weeks, A follow-up chest CT with enhancement showed that the tumor volume and lymph nodes in the 7 group had significantly decreased compared to before with (RECIST) version 1.1 evaluation showing PR (Figures 8C, D).